BIO.B

Bio-Rad Laboratories, Inc. Class B · NYSE

Sector Health Technology
Industry Medical Specialties
Website -
Employees(FY) -
ISIN US0905721082

Performance

-11.19%

-9.11%

-0.89%

+10.08%

+0.15%

YTD

+6.19%

Profile

Advanced Technical Analysis

Technical Analysis of BIO.B 2024-10-03

The stock exhibits a strong bullish sentiment with a Moving Average Score of 83, indicating robust upward momentum, while the Technical Score of 65 further supports this positive outlook. However, the Oscillators Score of 46 suggests a neutral stance, indicating potential consolidation or a pause in the upward trend, which investors should monit...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of BIO.B

Stock Rank

Recent News & Updates

2024-11-13 08:46
What Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity?(Insider Monkey)
2024-11-12 19:00
BIO: Lowering target price to $292.00(Argus Research)
2024-11-05 19:00
BIO: Raising target price to $299.00(Argus Research)
2024-11-04 09:15
Interpreting Bio-Rad (BIO) International Revenue Trends(Zacks)
2024-11-02 08:23
Bio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates(Simply Wall St.)
2024-11-01 06:43
Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023)(Simply Wall St.)
2024-10-31 12:36
Q3 2024 Bio Rad Laboratories Inc Earnings Call(Thomson Reuters StreetEvents)
2024-10-31 11:52
Analyst Report: Bio-Rad Laboratories, Inc.(Morningstar Research)
2024-10-31 11:27
UBS Adjusts Price Target on Bio-Rad Laboratories to $390 From $400, Maintains Buy Rating(MT Newswires)
2024-10-31 09:00
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference(Business Wire)
2024-10-31 08:42
BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket(Zacks)
2024-10-31 03:18
Bio-Rad Laboratories Inc (BIO) Q3 2024 Earnings Call Highlights: Strong Clinical Diagnostics ...(GuruFocus.com)
2024-10-30 17:50
Bio-Rad Laboratories (BIO) Beats Q3 Earnings and Revenue Estimates(Zacks)
2024-10-30 16:48
Bio-Rad: Q3 Earnings Snapshot(Associated Press Finance)
2024-10-30 16:15
Bio-Rad Reports Third-Quarter 2024 Financial Results(Business Wire)
2024-10-29 11:26
What to Expect From These 3 MedTech Stocks This Earnings Season(Zacks)
2024-10-25 06:34
Shareholders in Bio-Rad Laboratories (NYSE:BIO) have lost 58%, as stock drops 4.6% this past week(Simply Wall St.)
2024-10-23 10:02
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for(Zacks)
2024-10-23 05:00
FitLife Brands (FTLF) Soars 5.7%: Is Further Upside Left in the Stock?(Zacks)
2024-10-17 12:04
BIO Gears Up for Q3 Earnings: Here's What You Need to Know(Zacks)
2024-10-15 10:44
Bio-Rad Laboratories (BIO) is a Classic Ariel Stock: Ariel Fund(Insider Monkey)
2024-10-14 17:30
Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024(Business Wire)
2024-10-10 15:03
BANK OF NOVA SCOTIA's Strategic Acquisition in Bio-Rad Laboratories Inc(GuruFocus.com)
2024-10-08 20:00
BIO: Raising target price to $274.00(Argus Research)
2024-10-01 10:06
Should You Continue to Hold Bio-Rad Stock in Your Portfolio?(Zacks)
2024-10-01 06:41
Citigroup Upgrades Bio-Rad Laboratories to Buy From Neutral, Adjusts Price Target to $400 From $350(MT Newswires)
2024-09-09 16:01
Palantir Soars, Dell Pops As Big AI Plays Finally Get S&P 500 Nod(Investor's Business Daily)
2024-09-09 10:56
Palantir and Dell Will Join S&P 500—What You Need To Know(Investopedia)
2024-09-09 07:24
Palantir Stock Jumps on S&P 500 Addition. Here’s Who Else Was Added.(Barrons.com)
2024-09-06 20:07
Palantir, Dell Will Finally Join The S&P 500. The Stocks Are Jumping.(Investor's Business Daily)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.